ClinicalTrials.govpublic full text
A Phase I Pharmacokinetic Study of Fluticasone Furoate /Umeclidinium Bromide/Vilanterol (100/62.5/25 Microgram [mcg]) After Single and Repeat Dose Administration From a Dry Powder Inhaler in Healthy Chinese Subjects
pulmonary disease, chronic obstructive, long-acting muscarinic antagonist, long-acting beta2 agonist, dry powder inhaler, inhaled corticosteroid, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 805367
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.